Citigroup Inc Spectrum Pharmaceuticals Inc Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.43 - $1.56 $901 - $3,269	-2,096 Reduced 50.38%	2,064 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.7 - $1.4 $7,431 - $14,863	-10,617 Reduced 71.85%	4,160 $3,000
Q1 2022 May 12, 2022	SELL	$0.63 - $1.59 $72,816 - $183,775	-115,582 Reduced 88.66%	14,777 $19,000
Q4 2021 Feb 10, 2022	SELL	$1.27 - $2.42 $504,285 - $960,921	-397,075 Reduced 75.28%	130,359 $166,000
Q3 2021 Nov 10, 2021	BUY	$2.15 - $3.82 $1.13 Million - $2.01 Million	527,434 New	527,434 $1.15 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.